Impact of positive thyroid autoimmunity on pregnant women with subclinical hypothyroidism. 2018

Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Departamento de Medicina, Facultad de Medicina, Universidad de Cádiz, Cádiz, España. Electronic address: cristinalopeztinoco@gmail.com.

BACKGROUND The impact of subclinical hypothyroidism (SH) and thyroid autoimmunity on obstetric and perinatal complications continues to be a matter of interest and highly controversial. OBJECTIVE To assess the impact of SH and autoimmunity in early pregnancy on the obstetric and perinatal complications in our population. METHODS A retrospective cohort study in 435 women with SH (TSH ranging from 3.86 and 10 μIU/mL and normal FT4 values) in the first trimester of pregnancy. Epidemiological and clinical parameters were analyzed and were related to obstetric and perinatal complications based on the presence of autoimmunity (thyroid peroxidase antibodies [TPO] > 34 IU/mL). RESULTS Mean age was 31.3 years (SD 5.2). Seventeen percent of patients had positive TPO antibodies. Presence of positive autoimmunity was associated to a family history of hypothyroidism (P=.04) and a higher chance of miscarriage (P=.009). In the multivariate analysis, positive TPO antibodies were associated to a 10.25-fold higher risk of miscarriage. No statistically significant associations were found with all other obstetric and perinatal complications. CONCLUSIONS In our region, pregnant women with SH and thyroid autoimmunity had a higher risk of miscarriage but not of other obstetric and perinatal complications.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011264 Pregnancy Trimesters The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation. Trimesters, Pregnancy,Pregnancy Trimester,Trimester, Pregnancy
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000022 Abortion, Spontaneous Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference. Abortion, Tubal,Early Pregnancy Loss,Miscarriage,Spontaneous Abortion,Abortions, Spontaneous,Abortions, Tubal,Early Pregnancy Losses,Loss, Early Pregnancy,Losses, Early Pregnancy,Miscarriages,Pregnancy Loss, Early,Pregnancy Losses, Early,Spontaneous Abortions,Tubal Abortion,Tubal Abortions

Related Publications

Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
May 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
May 2022, Journal of midwifery & women's health,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
April 2019, JBRA assisted reproduction,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
July 1994, The Journal of clinical endocrinology and metabolism,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
March 2018, The Journal of clinical endocrinology and metabolism,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
September 2021, Clinical and experimental pharmacology & physiology,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
January 2017, BMJ (Clinical research ed.),
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
June 2016, Clinical endocrinology,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
November 2015, JAMA internal medicine,
Cristina López-Tinoco, and Amparo Rodríguez-Mengual, and Almudena Lara-Barea, and Julia Barcala, and Laura Larrán, and Ana Saez-Benito, and Manuel Aguilar-Diosdado
March 2021, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!